Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir.
Nicola SquillaceElena RicciPaolo MaggiLucia TaramassoBarbara MenzaghiGiuseppe Vittorio De SocioStefania PiconiBenedetto Maurizio CelesiaGiancarlo OrofinoEleonora SarchiGiovanni Francesco PellicanòFilomena SimeoneLaura ValsecchiAlessandra BanderaGiovanni CenderelloLetizia AttalaGoffredo AngioniKatia FalascaAntonio CascioOlivia BargiacchiAntonio Di BiagioPaolo Bonfantinull nullPublished in: PloS one (2023)
In ART-experienced PLWH switching to FTC/TAF/BIC a significant improvement of lipid profile occurred but with significant BG and ALT variation without clinical relevance. In ART-naïve PLWH, blood lipids increased even though lipid profile did not worsen, and a trend towards normalization of liver enzymes was suggested. FTC/TAF/BIC is well tolerated in the real life setting.